Navigation Links
Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
Date:8/19/2007

efractory multiple myeloma who have received at least two lines of therapy, and whose disease progressed on their most recent therapy. Prior therapy must have included bortezomib (VELCADE(R)) or lenalidomide.

LBH589 is part of a promising class of drugs called deacetylase inhibitors or HDAC inhibitors, which may play an important role in helping to slow or stop the growth of multiple myeloma cells. Preclinical laboratory data suggests that LBH589 has significant activity against multiple myeloma cells, including those that are resistant to conventional therapies.

About the Multiple Myeloma Research Consortium (MMRC)

The Multiple Myeloma Research Consortium (MMRC) is a 509(a)3 non-profit organization that integrates leading academic institutions to accelerate drug development in multiple myeloma. It is led from MMRC offices in Norwalk, Conn., and comprises 13 member institutions: City of Hope, Dana-Farber Cancer Institute, Emory University's Winship Cancer Institute, the Cancer Center at Hackensack University Medical Center, H. Lee Moffitt Cancer Center & Research Institute, Mayo Clinic, Ohio State University, Roswell Park Cancer Institute, St. Vincent's Comprehensive Cancer Center of Saint Vincent Catholic Medical Centers of New York, University Health Network (Princess Margaret Hospital), University of Chicago, University of Michigan, and Washington University.

The MMRC was founded in 2004 by Kathy Giusti, a myeloma patient, and with the help of the scientific community. The MMRC is a sister organization to the Multiple Myeloma Research Foundation (MMRF), the world's leading funder of multiple myeloma research. The MMRC is widely recognized as an optimal research model to rapidly address critical challenges in drug development and to explore opportunities in the today's most promising research areas -- genomics, compound validation, and clinical trials. The MMRC is the only consortium to join academic institutions through membership agreemen
'/>"/>

SOURCE The Multiple Myeloma Research Consortium

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Gentiums Defibrotide Seen as Active in Multiple Myeloma
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
10. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
11. Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax Demonstrating Marked Expansion of Regulatory T Cell Populations in Patients With Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 , Elbit Imaging ... EMITF ) announced today following the Company,s announcement dated ... Medical") (TASE: EMTC-M), a subsidiary of the Company in ... basis, announced that on September 1, 2014 Gamida Cell ... the voting power ("Gamida Cell") and vast majority of ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014 Cepheid ... Flu/RSV XC, an on-demand molecular test for ... Flu B, and differentiation of RSV infection. The ... under the European Directive on In Vitro ... of tests available to eighteen. Xpert Flu/RSV XC runs ...
(Date:9/2/2014)... New York , September 2, 2014 ... " Biological Drugs Market - Global Industry Analysis, ... is expected to grow at a CAGR of 10.1% ... typically derived from living cells and are used in ... cancer, blood-related diseases, auto-immune diseases and other medical disorders. ...
Breaking Medicine Technology:Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 2Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 2CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 3CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 5CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 6
... TECH ) announced that its Board of Directors has ... the quarter ended September 30, 2010.  The quarterly dividend will ... record on November 8, 2010.  Future cash dividends will be ... Techne Corporation has two operating subsidiaries:  Research and ...
... ALTO, Calif., Oct. 28 Jazz Pharmaceuticals, Inc. (Nasdaq: ... third quarter 2010 financial results on Thursday, November 4, 2010 ... will discuss its financial results and guidance for 2010, and ... and press release may be accessed from the Investors section ...
Cached Medicine Technology:
(Date:9/2/2014)... Durable Medical Goods manufacture ThermoTek , ... financing company LeaseQ, Inc. to help customers acquire capital ... 2012, LeaseQ’s breakthrough finance shopping platform has enabled businesses ... to run their business. , Said LeaseQ Vice ... ThermoTek sales team to provide customers faster access to ...
(Date:9/2/2014)... The American Healthcare Documentation Professionals Group (AHDPG) ... its ICD-10 Medical Coding Bridge Program. The purpose of ... confidence to students who are seeking to launch an ... with the uncertainty brought on by the federal government’s ... 1st, 2015. , AHDPG’s Free-Tuition Guarantee is simple and ...
(Date:9/2/2014)... News) -- The quality of Americans, diets has improved ... the rich and poor is growing, a new study ... to date that the extensive efforts by many groups ... some payoff, but it also indicates that these efforts ... doctoral student in the department of nutrition at the ...
(Date:9/2/2014)... By Amy Norton ... -- For people who want to lose weight and boost ... than trimming dietary fat, a new study suggests. In ... those assigned to follow a low-carbohydrate diet lost more weight ... They also had bigger improvements in their cholesterol and ...
(Date:9/2/2014)... PA (PRWEB) September 02, 2014 The ... Rehabilitation Hospital returns on September 19 at The ACE ... Pennsylvania. Over the past 25 years, the Classic, organized ... than $12 million for programs and services designed to ... Magee Rehabilitation Hospital. , “The Segal Classic is ...
Breaking Medicine News(10 mins):Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3Health News:Quality of U.S. Diet Improves, Slightly 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 3Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2
... ... can now take advantage of its platform for rapid delivery of custom business applications. ,Formotus ... the first time today at the Mobile World Congress. Formotus demonstrated its mobile software in ... Barcelona, ...
... ... Georgia has become the company’s Vice President of Product Services. Among his responsibilities, Randy ... & Notification Network, White Pine’s flagship personal health record solution. , ... (PRWEB) February 14, 2010 -- ...
... ... Society of Aesthetic Plastic Surgery indicates a 162 percent increase in aesthetic ... continuing to rise, many men and women consider a tummy tuck (abdominoplasty) ... appropriate for their needs. At his practice offering plastic surgery in ...
... , ... Training and Consulting Inc., is bringing a unique approach to the Continuous Process Improvement ... one business strategy. , ... Denver, CO (PRWEB) February 15, 2010 -- Mountain Home Training and Consulting Inc., ...
... in the Feb. 15 issue of the Journal of ... and poor sleep quality significantly increase the risk of motor ... were twice as likely to have had a crash if ... or reported having bad sleep (OR = 1.9). Eighty ...
... might not be the best way to learn what to ... popular medical dramas and found that doctors and nurses on ... according to a study released today that will be presented ... Toronto April 10 to April 17, 2010. "Television dramas ...
Cached Medicine News:Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 2Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 3Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 4Health News:Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services 2Health News:Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise 2Health News:Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise 3Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 2Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 3Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 4Health News:Sleep problems and sleepiness increase the risk of motor vehicle accidents in adolescents 2
... only powered 6-inch dermatome on the market. ... adult hands or a small child's face ... to run more efficiently, thus the motor ... temperature is much cooler. The Electro-Dermatome is ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
Corneal rust ring remover battery powered, extra burr 1.0 mm....
BD Visitec IOL Manipulator (Sinskey), blunt tip angled 45, 15.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles han...
Medicine Products: